ConductScience.org, home

Paper18190835

New frontiers in nanotechnology for cancer treatment.

Alexis F and 5 others. Urol Oncol, 2008. Cited by 205 papers, by iCite.

Cite this record

ConductScience Library. New frontiers in nanotechnology for cancer treatment. Papers, record 18190835. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18190835

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New frontiers in nanotechnology for cancer treatment.
PubMed
Journal
Urol Oncol
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
205
iCite
Relative citation ratio, by iCite
5.66
iCite
Revised in PubMed
2015-11-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alexis FFrank
2Rhee JWJune-Wha
3Richie JPJerome P
4Radovic-Moreno AFAleksandar F
5Langer RRobert
6Farokhzad OCOmid C

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NanotechnologyMajor topic
Urologic NeoplasmsMajor topic
Dendrimers
Drug Delivery Systems
Drug Design
Humans

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA119349NCI NIH HHSUnited StatesU54CA119349PubMed and NIHNIH RePORTER
EB003647NIBIB NIH HHSUnited StatesK08EB003647PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by87

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 205 citations.

PMIDTitleJournalYearIn PapersSource
42334650Immune-smart nanocarriers for nucleic acid oncology: engineering biomaterials for safe, precise, and durable responses.Mol Biol Rep2026https://conductscience.org/library/papers/42334650PubMed
41814097Exploring the anticancer potential of epigallocatechin gallate-loaded sodium alginate nanoparticles: impact of size variation on head and neck cancer cells.Clin Transl Oncol2026https://conductscience.org/library/papers/41814097PubMed
40837709Revolutionizing healthcare: the transformative potential of nanotechnology in medicine.Front Drug Deliv2025https://conductscience.org/library/papers/40837709PubMed
40808199Enhanced Anticancer Activity of Atractylodin-Loaded Poly(lactic-co-glycolic Acid) Nanoparticles Against Cholangiocarcinoma.Polymers (Basel)2025https://conductscience.org/library/papers/40808199PubMed
39408718Nanomedicine in Bladder Cancer Therapy.Int J Mol Sci2024https://conductscience.org/library/papers/39408718PubMed
39164280Investigation of antibacterial and anticancer activities of copper, aluminum and nickel doped zinc sulfide nanoparticles.Sci Rep2024https://conductscience.org/library/papers/39164280PubMed
38473773Mesoporous Silicon Nanoparticles with Liver-Targeting and pH-Response-Release Function Are Used for Targeted Drug Delivery in Liver Cancer Treatment.Int J Mol Sci2024https://conductscience.org/library/papers/38473773PubMed
37747575Borophene as an carrier for mercaptopurine drug: electronic study via density-functional theory computations.J Mol Model2023https://conductscience.org/library/papers/37747575PubMed
37711175Dual-targeting peptides@PMO, a mimetic to the pro-apoptotic protein Smac/DIABLO for selective activation of apoptosis in cancer cells.Front Pharmacol2023https://conductscience.org/library/papers/37711175PubMed
37664074Research trends and hot spots in global nanotechnology applications in liver cancer: a bibliometric and visual analysis (2000-2022).Front Oncol2023https://conductscience.org/library/papers/37664074PubMed
37446806Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials.Molecules2023https://conductscience.org/library/papers/37446806PubMed
37376042Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review.Pharmaceutics2023https://conductscience.org/library/papers/37376042PubMed
37152471Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles Encapsulating Fenbendazole and Rapamycin in Ovarian Cancer.Int J Nanomedicine2023https://conductscience.org/library/papers/37152471PubMed
37125102Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities.ACS Omega2023https://conductscience.org/library/papers/37125102PubMed
37024610Toxicity evaluation of silica nanoparticles for delivery applications.Drug Deliv Transl Res2023https://conductscience.org/library/papers/37024610PubMed
36972480Optimizing Conjugation Chemistry, Antibody Conjugation Site, and Surface Density in Antibody-Nanogel Conjugates (ANCs) for Cell-Specific Drug Delivery.Bioconjug Chem2023https://conductscience.org/library/papers/36972480PubMed
36911792A predictive model for personalization of nanotechnology-based phototherapy in cancer treatment.Front Oncol2022https://conductscience.org/library/papers/36911792PubMed
36145657Nano-Formulation Based Intravesical Drug Delivery Systems: An Overview of Versatile Approaches to Improve Urinary Bladder Diseases.Pharmaceutics2022https://conductscience.org/library/papers/36145657PubMed
35646923Tumor-Derived Lactate Creates a Favorable Niche for Tumor via Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment.Front Cell Dev Biol2022https://conductscience.org/library/papers/35646923PubMed
35517745Amino acid-modified PAMAM dendritic nanocarriers as effective chemotherapeutic drug vehicles in cancer treatment: a study using zebrafish as a cancer model.RSC Adv2020https://conductscience.org/library/papers/35517745PubMed

See all 87 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18190835

GET https://conductscience.org/api/papers/v1/18190835/cited_by?page=2